JP Morgan Chase’s Rallybio RLYB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$20.1K Buy
2,497
+2,487
+24,870% +$17K ﹤0.01% 6539
2025
Q4
$56 Sell
10
-100
-91% -$515 ﹤0.01% 7256
2025
Q3
$440 Hold
110
﹤0.01% 7062
2025
Q2
$298 Sell
110
-8
-7% -$21 ﹤0.01% 6746
2025
Q1
$618 Sell
118
-1
-0.8% -$6 ﹤0.01% 6677
2024
Q4
$910 Buy
119
+9
+8% +$75 ﹤0.01% 6744
2024
Q3
$1.03K Hold
110
﹤0.01% 6718
2024
Q2
$1.18K Sell
110
-1,714
-94% -$23.2K ﹤0.01% 6591
2024
Q1
$27K Sell
1,824
-673
-27% -$9.38K ﹤0.01% 6145
2023
Q4
$47.7K Hold
2,497
﹤0.01% 6013
2023
Q3
$67.3K Sell
2,497
-588
-19% -$25.5K ﹤0.01% 5696
2023
Q2
$140K Sell
3,085
-835
-21% -$40.9K ﹤0.01% 5290
2023
Q1
$179K Buy
3,920
+2,500
+176% +$129K ﹤0.01% 5126
2022
Q4
$74K Buy
1,420
+70
+5% +$4.13K ﹤0.01% 5474
2022
Q3
$156K Buy
1,350
+99
+8% +$8.82K ﹤0.01% 5063
2022
Q2
$75K Sell
1,251
-296
-19% -$22.2K ﹤0.01% 5535
2022
Q1
$86K Sell
1,547
-39,480
-96% -$3.27M ﹤0.01% 5581
2021
Q4
$3.13M Buy
41,027
+34,151
+497% +$3.97M ﹤0.01% 3454
2021
Q3
$967K Buy
+6,876
New +$806K ﹤0.01% 4335

Other funds holding RLYB

JP Morgan Chase's RLYB Position: Q1 2026 in Review

JP Morgan Chase increased its Rallybio (RLYB) stake by 24,870% in Q1 2026, buying an estimated $17K and bringing the position to 2,497 shares worth $20.1K. The position accounts for ﹤0.01% of the portfolio, ranked #6539.

JP Morgan Chase first reported a position in RLYB in Q3 2021 and has held it in 19 quarters since. The position peaked at $3.13M in Q4 2021. 38 funds tracked by Wall St. Rank hold RLYB as of Q1 2026.

  • JP Morgan Chase held 2,497 shares of Rallybio worth $20.1K as of Q1 2026.
  • JP Morgan Chase bought 2,487 Rallybio shares in Q1 2026, an estimated $17K.
  • Rallybio made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #6539 holding.
  • JP Morgan Chase first reported a position in Rallybio in Q3 2021 and has held it in 19 quarters since.
  • JP Morgan Chase's Rallybio position peaked at $3.13M in Q4 2021.
  • 38 funds tracked by Wall St. Rank held Rallybio as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.